SEC Form 4 · accession 0001104659-18-073330
Replimune Group, Inc. · REPL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pamela Esposito
Officer — Chief Business Officer
Period of report
Dec 13, 2018
Accepted (ET)
Dec 17, 2018 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001737953
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 13, 2018 | M | 87,000 | $1.75 | A | 87,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.75 | Dec 13, 2018 | M | 87,000 | D | — | Mar 1, 2026 | Common Stock | 87,000 | 109,162 | D |
Explanation of responses
- F1The reporting person was granted a stock option to acquire 196,162 shares of the Issuer's common stock, subject to vesting. 134,846 shares underlying the stock option have vested with the remaining 61,316 shares underlying the stock option to vest in 15 equal monthly installments as of the 29th of each month.